Cited 0 times in
MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.